Respiratory Medicine
Volume 103, Issue 8 , Pages 1216-1223 , August 2009

Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering

  • M. van den Berge

      Affiliations

    • Department of Pulmonology, University Medical Center Groningen, Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Pulmonary Diseases, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. Tel.: +31 (0)50 3616161; fax: +31 (0)50 3619320.
    • ,
  • S.H. Arshad

      Affiliations

    • Department of Pulmonology, University Hospital of North Staffordshire, Newcastle, United Kingdom
    • ,
  • P.W. Ind

      Affiliations

    • Department of Pulmonology, Hammersmith Hospital, London, United Kingdom
    • ,
  • H. Magnussen

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Grosshansdorf, Germany
    • ,
  • E. Hamelmann

      Affiliations

    • Department of Pulmonology, Charité Universitätsmedizin, Berlin, Germany
    • ,
  • F. Kanniess

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Grosshansdorf, Germany
    • Present address: KLB Health Research, Lübeck, Germany.
    • ,
  • D.S. Postma

      Affiliations

    • Department of Pulmonology, University Medical Center Groningen, Groningen, The Netherlands

Received 7 October 2008 ,Accepted 27 January 2009.

References 

  1. Johnston SL. Mechanisms of asthma exacerbation. Clin Exp Allergy. 1998;28(Suppl. 5):181–186
  2. Smith R. Corticosteroids and osteoporosis. Thorax. 1990;45:573–578
  3. Nana A, Youngchaiyud P, Charoenratanakul S, Boe J, Lofdahl CG, Selroos O, et al. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack. J Asthma. 1998;35:647–655
  4. Jenkins CR, Woolcock AJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax. 1988;43:378–384
  5. Bosman HG, van Uffelen R, Tamminga JJ, Paanakker LR. Comparison of inhaled beclomethasone dipropionate 1000 micrograms twice daily and oral prednisone 10 mg once daily in asthmatic patients. Thorax. 1994;49:37–40
  6. Levy ML, Stevenson C, Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax. 1996;51:1087–1092
  7. Meijer RJ, Kerstjens HAM, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax. 1999;54:894–899
  8. Lee-Wong M, Dayrit FM, Kohli AR, Acquah S, Mayo PH. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. Chest. 2002;122:1208–1213
  9. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest. 2004;125:1081–1102
  10. Ketchell RI, D'Amato M, Jensen MW, O'Connor BJ. Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthma. Thorax. 2002;57:575–580
  11. Gibson PG, Dolovich J, Denburg JA, Girgis-Gabardo A, Hargreave FE. Sputum cell counts in airway disease: a useful sampling technique. Agents Actions Suppl. 1990;30:161–172
  12. Harrison TW, Tattersfield AE. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax. 2003;58:258–260
  13. Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest. 2005;127:851–860
  14. Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy. 1992;22:525–532
  15. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995;95:843–852
  16. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000;161:64–72
  17. in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med. 1999;160:93–99
  18. Di Franco A, Bacci E, Bartoli ML, Cianchetti S, Dente FL, Taccola M, et al. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. Pulm Pharmacol Ther. 2006;19:353–360
  19. Wilson AM, Lipworth BJ. Short-term dose–response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults. Br J Clin Pharmacol. 1999;48:579–585
  20. Nielsen LP, Dahl R. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir Crit Care Med. 2000;162:2053–2057
  21. Mutch E, Nave R, McCracken N, Zech K, Williams FM. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem Pharmacol. 2007;73:1657–1664
  22. Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen BK, et al. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol. 2003;43:365–378
  23. Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic–pituitary–adrenal axis function in patients with moderate-to-severe persistent asthma. Chest. 2005;128:1104–1114
  24. Vermeulen JH, Gyurkovits K, Rauer H, Engelstatter R. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. Respir Med. 2007;101:2182–2191
  25. Pearlman DS, Berger WE, Kerwin E, Laforce C, Kundu S, Banerji D. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. J Allergy Clin Immunol. 2005;116:1206–1212
  26. Belda J, Margarit G, Martinez C, Bellido-Casado J, Casan P, Torrejon M, et al. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. Eur Respir J. 2007;30:1143–1149

PII: S0954-6111(09)00040-7

doi: 10.1016/j.rmed.2009.01.024

Respiratory Medicine
Volume 103, Issue 8 , Pages 1216-1223 , August 2009

Article Tools

* Image Usage & Resolution